Vivos Therapeutics
Post in 2024
Vivos Therapeutics, Inc. is a medical technology company based in Highlands Ranch, Colorado, focused on developing and commercializing innovative solutions for patients suffering from sleep disordered breathing, particularly mild to moderate obstructive sleep apnea (OSA). The company's flagship offering, the Vivos System, provides a non-surgical, non-invasive, and cost-effective treatment that utilizes customized oral appliances and specialized treatment protocols to modify the size, shape, and position of airway tissues. This approach aims to open airway space and alleviate symptoms associated with OSA. Vivos Therapeutics also supports its network of healthcare providers, including general dentists and medical professionals, by offering training and access to its technology. Additionally, the company licenses its intellectual property to third-party manufacturers for the production of appliance devices. Established in 2007, Vivos Therapeutics has positioned itself as a leader in addressing sleep disordered breathing in the United States and Canada.
ADC Biotechnology
Venture Round in 2018
ADC Biotechnology Ltd is a UK-based company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment. Founded in 2010 and formerly known as Reaxa Biotech Ltd, the company has created a patented Lock-Release technology that streamlines the drug purification process by reducing the number of steps and associated risks. This innovative approach not only simplifies the development of ADCs but also lowers costs for drug developers. In addition to its proprietary technology, ADC Biotechnology offers a range of consultancy and research and development services to support the testing and production of new ADC-based therapies aimed at specifically targeting and destroying tumor cells.
SuperCarers
Series A in 2018
SuperCarers is a company that facilitates connections between families seeking home care and independent caregivers in Warrington, United Kingdom. The company offers a comprehensive online platform that allows families to find and book various types of care, including live-in care, daycare, night care, and specialized support for conditions such as Alzheimer’s, dementia, and cancer. By providing a personal matchmaking service, SuperCarers empowers families to manage scheduling, logistics, and payments directly with caregivers. This approach not only fosters trust between families and local carers but also ensures that caregivers can earn a living wage while delivering essential support services.
BondMason
Venture Round in 2018
BondMason Ltd, established in 2014, operates a UK-based online investment platform that facilitates access to peer-to-peer (P2P) lending opportunities. The company sources loans from approved P2P platforms and offers investors diversified selections to optimize returns. BondMason focuses on providing insights, analysis, and access to investment opportunities within the UK residential property market through its platform.
ADC Biotechnology
Venture Round in 2017
ADC Biotechnology Ltd is a UK-based company specializing in the development of antibody-drug conjugates (ADCs) for cancer treatment. Founded in 2010 and formerly known as Reaxa Biotech Ltd, the company has created a patented Lock-Release technology that streamlines the drug purification process by reducing the number of steps and associated risks. This innovative approach not only simplifies the development of ADCs but also lowers costs for drug developers. In addition to its proprietary technology, ADC Biotechnology offers a range of consultancy and research and development services to support the testing and production of new ADC-based therapies aimed at specifically targeting and destroying tumor cells.
Redag Crop
Venture Round in 2017
Redag Crop Protection is a producer of innovative crop protection products designed to address the challenges of declining innovation in the agrochemical sector. Utilizing the Redox Switch™ approach, the company develops a range of products including fungicides, herbicides, insecticides, and nematicides. This method not only focuses on identifying best-in-class crop protection solutions but also fosters the creation of new intellectual property that supports the development of novel agrochemicals. With shorter and more cost-effective development cycles, Redag Crop Protection is positioned to respond rapidly to the industry's evolving needs as older products are phased out for safety reasons or diminished efficacy due to resistance. Ultimately, the company aims to enhance sustainable food production by enabling farmers to effectively safeguard their crops against pests.
Vapour Media
Venture Round in 2017
Vapour Cloud is a West Yorkshire cloud technology provider to SME resellers. Vapour provides SME resellers with the point of access to highly competent independent, private network infrastructure, a choice of leading network providers, and a scalable platform for growth, backed by comprehensive training and fully managed installation and support.
Vapour Media
Venture Round in 2016
Vapour Cloud is a West Yorkshire cloud technology provider to SME resellers. Vapour provides SME resellers with the point of access to highly competent independent, private network infrastructure, a choice of leading network providers, and a scalable platform for growth, backed by comprehensive training and fully managed installation and support.
Redag Crop
Venture Round in 2016
Redag Crop Protection is a producer of innovative crop protection products designed to address the challenges of declining innovation in the agrochemical sector. Utilizing the Redox Switch™ approach, the company develops a range of products including fungicides, herbicides, insecticides, and nematicides. This method not only focuses on identifying best-in-class crop protection solutions but also fosters the creation of new intellectual property that supports the development of novel agrochemicals. With shorter and more cost-effective development cycles, Redag Crop Protection is positioned to respond rapidly to the industry's evolving needs as older products are phased out for safety reasons or diminished efficacy due to resistance. Ultimately, the company aims to enhance sustainable food production by enabling farmers to effectively safeguard their crops against pests.
Evgen Pharma
Venture Round in 2015
Evgen Pharma is a clinical stage drug development company headquartered in Wilmslow, United Kingdom, focused on creating sulforaphane-based medicines for various diseases, particularly cancer and neurological conditions. The company's proprietary technology, Sulforadex, consists of synthetic and stabilized analogues of sulforaphane, a compound recognized for its potential therapeutic benefits. Evgen's lead product, SFX-01, is a synthetic version of sulforaphane that is currently undergoing Phase II clinical trials for metastatic breast cancer and subarachnoid hemorrhage. Additionally, SFX-01 is in preclinical development for multiple sclerosis and is also being studied for its efficacy in treating prostate cancer, autism, non-alcoholic steatohepatitis, and chronic kidney diseases. Founded in 2007, Evgen Pharma aims to transform scientific research into commercially viable treatments.
The Insurance Surgery
Acquisition in 2015
The Insurance Surgery Ltd. is a specialized insurance provider based in Macclesfield, United Kingdom, focusing on life and travel insurance for clients with pre-existing medical conditions and other special risks. Established in 1999, the company caters to a wide range of medical conditions, including diabetes, multiple sclerosis, cancer, epilepsy, and asthma. Its offerings encompass various insurance products such as life and travel insurance tailored for specific health issues, enhanced annuities, income protection, key man insurance, and critical illness insurance. Additionally, The Insurance Surgery provides services like private medical insurance, health cash plans, and general financial advice. With a commitment to exceptional customer service, the company has earned a strong reputation for helping individuals, families, and businesses secure appropriate coverage, particularly for those deemed high-risk by traditional insurers.
Rockar Limited is a UK-based company that specializes in providing online car retail services. Founded in 2011 and headquartered in North Newbald, Rockar offers a comprehensive platform where customers can search for cars, sell their old vehicles, choose suitable finance options, customize their new car, and track the delivery process. The company aims to simplify the car-buying experience by eliminating traditional sales pressures and providing straightforward advice and pricing. Rockar's website allows customers to value their current car, find vehicles within their budget, and tailor payment plans to their needs. Additionally, Rockar Angels are available to assist customers with any questions or guidance throughout the purchasing journey.
myParcelDelivery
Seed Round in 2014
myParcelDelivery.com is the brainchild of two young and exciting entrepreneurs Paul Haydock and David Grimes. They both had the idea whilst trying to negotiate reasonable courier rates for another business, coupled with many hours waiting in the local post office. The realisation quickly dawned that it was not only businesses that needed access to reliable, trackable and cost effective courier services - but also small retailers, eBay Sellers and the general public. David and Paul then embarked on a 20 month development program to design a website that could perform beyond any perceivable competition. The result is myParcelDelivery.com™, which is focused on saving you time and money when sending (and receiving!) parcels. Every function of myParcelDelivery.com™ culminates in your successful sending of a UK based, or indeed an international parcel delivery. With an incredible team effort, our IT department has raised the bar in development standards to ensure that what we do is right for you. Our young and innovative team thrive on out-smarting our competitors in all areas, which has lead to the company racking up award after award (which you can read all about by following the links to the right)!
Cytox Limited is a company focused on developing innovative products and services for the diagnosis and treatment of neurodegenerative disorders, particularly Alzheimer's disease. Established in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox has created a genetic-based blood test that assesses the risk and early diagnosis of Alzheimer's disease, which currently affects millions worldwide. The company employs cellular and genetic assays to identify early cell cycle deficits in patients, aiding pharmaceutical and biotechnology companies in clinical trials and drug development for Alzheimer's and mild cognitive impairment. Cytox's strategic partnership with Affymetrix, part of Thermo Fisher Scientific, enhances its capabilities in delivering these assessments and supporting the development of novel therapeutics.
Celleration
Series E in 2011
Celleration Inc. is a privately held medical device company based in Eden Prairie, Minnesota, founded in 1999. The company specializes in developing and commercializing therapeutic ultrasound technologies for wound care. Its flagship product, the MIST Therapy System, utilizes low-frequency ultrasound delivered through a saline mist to promote healing in wounds. This innovative approach allows ultrasound energy to penetrate beyond the surface of the wound, stimulating cellular activity and enhancing the healing process. Since receiving FDA clearance in 2005, Celleration has established a strong presence in the U.S. market, with over 1 million MIST Therapy treatments performed, benefiting more than 65,000 patients across numerous healthcare facilities. Celleration's commitment to advancing wound care technology has resulted in significant clinical and economic benefits, reinforcing its role in the medical community.
Adesso AI
Venture Round in 2010
Adesso AI is a prominent provider of integrated technology solutions tailored for the Consumer Goods industry, focusing on small and medium-sized businesses. Established in 2002, the company offers a unique Trade Promotion Management (TPM) platform powered by a sophisticated AI engine and real-time data analytics. Adesso AI specializes in trade promotion and deduction management software, designed to enhance the effectiveness of clients' trade promotions both in the short and long term. The company’s expertise in account planning, forecasting, trade promotion spending, deduction resolution, and customer profitability distinguishes it from competitors, as its team comprises seasoned trade professionals with backgrounds in major Consumer Packaged Goods (CPG) companies. Additionally, Adesso AI prides itself on providing exceptional support to help clients achieve their trade spend management and broader business objectives.
This website is for sale! webputty.com is your first and best source for all of the information you’re looking for. From general topics to more of what you would expect to find here, webputty.com has it all. We hope you find what you are searching for!